August 2015

• Certificate of Merit for an initiative for knowledge dissemination & training in the area of good manufacturing practices (GMP) By Dr. R. P. Singh (Secretary general, QCI) and Mr. Hari K. Taneja (Trustee, D.L.Shah Trust) in 10th National Quality Conclave held on August 7-8, 2015 at Sirifort Auditorium, New Delhi.

The Annual Flagship event of QCI, the 10^th National Quality Conclave “Creating an Ecosystem for World Class Quality in India” with World Health Organization (as Technical Partner for Health Thematic Session) and ASQ (as the Knowledge Partner) held on August 7-8, 2015 in New Delhi. The Quality Conclave 2015 is a platform to know what the world has done and how India can build an Ecosystem of Quality in every sphere of life.

A new study has revealed that even moderate levels of stress can impair self-control. The scientists found that when individuals chose between different food options after having experienced the stressful ice bath treatment, they were more likely to choose an unhealthy food. The study published in the journal Neuron.

Researchers found In the fight against bovine spongiform encephalopathy, the incurable brain-wasting disease also known as mad cow disease, a new drug compound could lead to a breakthrough.

Hetero Group, one of India’s leading generic pharmaceutical companies  has recently announced the launch of its biosimilar ‘Rituximab’ under the brand name Maball in India. It will be marketed and distributed by Hetero Healthcare Limited, a group company of Hetero. Rituximab is recommended as the first-line treatment for NHL and is available in a single dose vial with two strengths – 100mg/10ml and 500mg/50ml.

Dr Reddy's Laboratories has entered into a strategic collaboration with Amgen to market and distribute three Amgen medicines in India in the areas of oncology and cardiology. Under the terms of the collaboration, DRL will launch Kyprolis (carfilzomib), Blincyto (blinatumomab and Repatha (evolocumab) in India.